CDMOP.PFD (Avid Bioservices) EV-to-EBITDA : 2.45 (As of Jun. 29, 2025)

View and export this data going back to 2014. Start your Free Trial

What is Avid Bioservices EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Avid Bioservices's enterprise value is $-35.20 Mil. Avid Bioservices's EBITDA for the trailing twelve months (TTM) ended in Oct. 2024 was $-14.34 Mil. Therefore, Avid Bioservices's EV-to-EBITDA for today is 2.45.

The historical rank and industry rank for Avid Bioservices's EV-to-EBITDA or its related term are showing as below:

CDMOP.PFD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -298.77 Med: -0.42 Max: 979.12
Current: -67.71

During the past 13 years, the highest EV-to-EBITDA of Avid Bioservices was 979.12. The lowest was -298.77. And the median was -0.42.

CDMOP.PFD's EV-to-EBITDA is not ranked
in the Biotechnology industry.
Industry Median: 8.94 vs CDMOP.PFD: -67.71

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-29), Avid Bioservices's stock price is $25.0602. Avid Bioservices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 was $0.000. Therefore, Avid Bioservices's PE Ratio (TTM) for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Avid Bioservices EV-to-EBITDA Historical Data

The historical data trend for Avid Bioservices's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices EV-to-EBITDA Chart

Avid Bioservices Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

EV-to-EBITDA

Get a 7-Day Free Trial

-45.49

79.31

44.82

108.55

-56.90

Avid Bioservices Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
EV-to-EBITDA	Get a 7-Day Free Trial															915.16	-75.85	-56.90	-67.19	-56.42

Competitive Comparison of Avid Bioservices's EV-to-EBITDA

For the Biotechnology subindustry, Avid Bioservices's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avid Bioservices's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's EV-to-EBITDA falls into.

Save Embed

;

Save Embed

;

Avid Bioservices EV-to-EBITDA Calculation

Avid Bioservices's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	-35.204	/	-14.341
	=	2.45

Avid Bioservices's current Enterprise Value is $-35.20 Mil.
Avid Bioservices's EBITDA for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.34 Mil.

Avid Bioservices (NAS:CDMOP.PFD) EV-to-EBITDA Explanation

Avid Bioservices's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	25.0602	/	0.000
	=	N/A

Avid Bioservices's share price for today is $25.0602.
Avid Bioservices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Avid Bioservices EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Avid Bioservices Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMOP.PFD) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

14191 Myford Road, Tustin, CA, USA, 92780

Website

https://www.avidbio.com

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.